Offer - Urjas Oil for just ₹ 1 X
Sezopam 0.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Sezopam 0.5 Tablet safe for pregnant women?
Sezopam can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Sezopam right away. Take your doctor's advice before taking it again.
Is the use of Sezopam 0.5 Tablet safe during breastfeeding?
Sezopam can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Sezopam 0.5 Tablet on the Kidneys?
Sezopam rarely harms the kidneys.
What is the effect of Sezopam 0.5 Tablet on the Liver?
Side effects of Sezopam rarely affect the liver.
What is the effect of Sezopam 0.5 Tablet on the Heart?
Sezopam is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Sezopam 0.5 Tablet unless your doctor advises you to do so -
Is this Sezopam 0.5 Tablet habit forming or addictive?
Yes, Sezopam 0.5 Tablet can get addictive. Consume it only after doctor's advise.
Is it safe to drive or operate heavy machinery when consuming?
After taking Sezopam 0.5 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Sezopam 0.5 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, this Sezopam 0.5 Tablet works for mental disorders.
Interaction between Food and Sezopam 0.5 Tablet
Sezopam 0.5 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Sezopam 0.5 Tablet
Consuming Sezopam 0.5 Tablet with alcohol can have many serious effects on your body.
Yes, Sezopam causes withdrawal symptoms when the drug is discontinued. These withdrawal symptoms can include new or worsening seizures, hallucinating (seeing things or hearing voices that do not exist), changes in behavior, sweating, uncontrollable shaking of a part of your body, stomach or muscle cramps, anxiety, or difficulty falling asleep or staying asleep.
Sezopam comes in form of a tablet and it should be taken by mouth once daily or as advised by your doctor. Precautions must be taken in patients with chronic pulmonary insufficiency, personality disorders, muscle weakness, impaired liver or kidney function. Do not drive any vehicle or operate machinery after taking this medicine as it can cause drowsiness or sedation.
No. Sezopam Should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, Sezopam causes dry mouth. It is a common side effect of it. If you experience excess dry mouth after taking this drug, please consult your doctor and follow his/her instructions.
Take Sezopam as advised by your doctor. Do not take it longer than prescribed. Initially, doctor prescribes this drug for a shorter duration and recommends his/her patient to follow- up/ re-visit to check for results. Taking this medicine longer than prescribed can lead to addiction because this is a habit-forming drug which can lead to drug dependency in patients.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Klonopin (clonazepam)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 418
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 330-332